Zobrazeno 1 - 10
of 29
pro vyhledávání: '"L. Friso"'
Autor:
Bernd Raffeiner, D. Astorri, Francesca Ometto, Leonardo Punzi, Costantino Botsios, L. Friso, Andrea Doria
Publikováno v:
Experimental Biology and Medicine. 242:859-873
Calprotectin is a heterodimer formed by two proteins, S100A8 and S100A9, which are mainly produced by activated monocytes and neutrophils in the circulation and in inflamed tissues. The implication of calprotectin in the inflammatory process has alre
Publikováno v:
Poster Presentations.
Background A definition of difficult-to-treat/refractory rheumatoid arthritis (RA) (RRA) has not been established yet, nevertheless, RRA is commonly associated with the resistance to multiple bDMARDs [1,2,3]. Objectives The objective was to evaluate
Autor:
L. Friso, Leonardo Punzi, Francesca Ometto, Bernd Raffeiner, Francesco Sartor, Astorri Davide, Andrea Doria, Costantino Botsios
Publikováno v:
Poster Presentations.
Background Gender differences may contribute to treatment tailoring in rheumatoid arthritis (RA) patients. Observational data shows a trend toward worse disease activity and worse response to treatment in females. Only few data are available specific
Publikováno v:
Annals of the Rheumatic Diseases. 79:1435.2-1436
Background::In recent years several biosimilars (BS) of tumour necrosis factor inhibitors (TNF-i) were introduced. At the Padova University Hospital the first BS of etanercept (bsETN) was available in October 2016 and the BS of adalimumab (bsADA) was
Publikováno v:
Annals of the Rheumatic Diseases. 79:625.1-625
Background:Three definitions of refractory rheumatoid arthritis (RRA) have been proposed: Buch’s (B-RRA), i.e. failure of ≥1 anti-cytokine and ≥1 cell-targeted bDMARD [1]; Kearsley-Fleet’s (KF-RRA), i.e. exposure to ≥3 bDMARDs classes [2];
Autor:
L. Friso, Bernd Raffeiner, Danila Azzolina, Costantino Botsios, Dario Gregori, D. Astorri, Marta Favero, Andrea Doria, Francesca Ometto, John Done
Publikováno v:
Rheumatoid arthritis – prognosis, predictors and outcome.
Background The 5-item Compliance Questionnaire for Rheumatology (CQR5) allows the identification of patients likely to be high adherers (HA) to anti-rheumatic treatment (i.e. taking ≥80% of their medications correctly), or “low” adherers (LA).1
Autor:
Francesca Ometto, L. Friso, Dario Gregori, Danila Azzolina, Andrea Doria, John Done, Bernd Raffeiner, Marta Favero, D. Astorri, Costantino Botsios
Publikováno v:
Rheumatoid arthritis – prognosis, predictors and outcome.
Background The 5-item Compliance Questionnaire for Rheumatology (CQR5) allows the identification of patients likely to be high adherers (HA) to anti-rheumatic treatment (i.e. taking ≥80% of their medications correctly), or “low” adherers (LA).
Autor:
Leonardo Punzi, Franco Cozzi, Francesca Ometto, D. Astorri, Roberto Padoan, Mara Felicetti, Mariele Gatto, Pamela Polito, Andrea Doria, L. Friso, Franco Schiavon
Publikováno v:
Poster Presentations.
Background Rituximab (RTX), a chimeric monoclonal antibody against CD20, is increasingly used in the treatment of B-cell lymphomas and autoimmune conditions. It has been shown that some patients develop hypogammaglobulinaemia after treatment. Objecti
Autor:
Francesca Ometto, Costantino Botsios, Leonardo Punzi, Bernd Raffeiner, L. Bernardi, L. Friso, Andrea Doria, D. Astorri
Publikováno v:
Abstracts Accepted for Publication.
Objectives To determine factors associated with remission (DAS28 Methods We conducted a retrospective analysis on a monocentric cohort of rheumatoid arthritis patients. We included patients who were on biologic drugs at the time of the analysis (31st
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.